mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.05 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.06 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.06 |